drugset / Trial / NCT00040573
Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This drug is being developed to treat a type of brain cancer, glioma. This study was designed to determine a safe and well tolerated dose. Patients must have had prior treatment for their glioma and be eligible for removal of their recurring tumor.
Timeline
- Start
- 2002-06
- Primary completion
- —
- Completion
- 2003-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 131I-TM601 | Peptide | — | Other |